Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Klebsiella Pneumoniae Infection Drug Revenue

1.5 Market Analysis by Type

1.5.1 Global Klebsiella Pneumoniae Infection Drug Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 ATI-1503

1.5.3 CA-824

1.5.4 CC-1807

1.5.5 Cefiderocol

1.5.6 Debio-1454

1.5.7 EBX-004

1.5.8 Others

1.6 Market by Application

1.6.1 Global Klebsiella Pneumoniae Infection Drug Market Share by Application: 2022-2027

1.6.2 Hospital

1.6.3 Clinic

1.6.4 Others

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Klebsiella Pneumoniae Infection Drug Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Klebsiella Pneumoniae Infection Drug Market Players Profiles

3.1 Acies Bio doo

3.1.1 Acies Bio doo Company Profile

3.1.2 Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Specification

3.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Appili Therapeutics

3.2.1 Appili Therapeutics Company Profile

3.2.2 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Specification

3.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Debiopharm International SA

3.3.1 Debiopharm International SA Company Profile

3.3.2 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Specification

3.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Evaxion Biotech ApS

3.4.1 Evaxion Biotech ApS Company Profile

3.4.2 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Specification

3.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 F. Hoffmann-La Roche Ltd

3.5.1 F. Hoffmann-La Roche Ltd Company Profile

3.5.2 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Specification

3.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 FOB Synthesis Inc

3.6.1 FOB Synthesis Inc Company Profile

3.6.2 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Specification

3.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 ImmunoClin Corp

3.7.1 ImmunoClin Corp Company Profile

3.7.2 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Specification

3.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Innovation Pharmaceuticals Inc

3.8.1 Innovation Pharmaceuticals Inc Company Profile

3.8.2 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Specification

3.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Kyorin Pharmaceutical Co Ltd

3.9.1 Kyorin Pharmaceutical Co Ltd Company Profile

3.9.2 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Specification

3.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Melinta Therapeutics Inc

3.10.1 Melinta Therapeutics Inc Company Profile

3.10.2 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Specification

3.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Nosopharm SAS

3.11.1 Nosopharm SAS Company Profile

3.11.2 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Specification

3.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Peptilogics Inc

3.12.1 Peptilogics Inc Company Profile

3.12.2 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Specification

3.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Pfizer Inc

3.13.1 Pfizer Inc Company Profile

3.13.2 Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Specification

3.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Phico Therapeutics Ltd

3.14.1 Phico Therapeutics Ltd Company Profile

3.14.2 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Specification

3.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.15 Sarepta Therapeutics Inc

3.15.1 Sarepta Therapeutics Inc Company Profile

3.15.2 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Specification

3.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.16 Shionogi & Co Ltd

3.16.1 Shionogi & Co Ltd Company Profile

3.16.2 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Specification

3.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.17 Syntiron LLC

3.17.1 Syntiron LLC Company Profile

3.17.2 Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Specification

3.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.18 Tetraphase Pharmaceuticals Inc

3.18.1 Tetraphase Pharmaceuticals Inc Company Profile

3.18.2 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Specification

3.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Klebsiella Pneumoniae Infection Drug Market Competition by Market Players

4.1 Global Klebsiella Pneumoniae Infection Drug Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Market Players (2016-2021)

4.3 Global Klebsiella Pneumoniae Infection Drug Average Price by Market Players (2016-2021)

5 Global Klebsiella Pneumoniae Infection Drug Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.1.2 Klebsiella Pneumoniae Infection Drug Key Players in North America (2016-2021)

5.1.3 North America Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.1.4 North America Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.2.2 Klebsiella Pneumoniae Infection Drug Key Players in East Asia (2016-2021)

5.2.3 East Asia Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.2.4 East Asia Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.3.2 Klebsiella Pneumoniae Infection Drug Key Players in Europe (2016-2021)

5.3.3 Europe Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.3.4 Europe Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.4.2 Klebsiella Pneumoniae Infection Drug Key Players in South Asia (2016-2021)

5.4.3 South Asia Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.4.4 South Asia Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.5.2 Klebsiella Pneumoniae Infection Drug Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.5.4 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.6.2 Klebsiella Pneumoniae Infection Drug Key Players in Middle East (2016-2021)

5.6.3 Middle East Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.6.4 Middle East Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.7.2 Klebsiella Pneumoniae Infection Drug Key Players in Africa (2016-2021)

5.7.3 Africa Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.7.4 Africa Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.8.2 Klebsiella Pneumoniae Infection Drug Key Players in Oceania (2016-2021)

5.8.3 Oceania Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.8.4 Oceania Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.9.2 Klebsiella Pneumoniae Infection Drug Key Players in South America (2016-2021)

5.9.3 South America Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.9.4 South America Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Klebsiella Pneumoniae Infection Drug Market Size (2016-2021)

5.10.2 Klebsiella Pneumoniae Infection Drug Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021)

5.10.4 Rest of the World Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021)

6 Global Klebsiella Pneumoniae Infection Drug Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Klebsiella Pneumoniae Infection Drug Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Klebsiella Pneumoniae Infection Drug Consumption by Countries

7 Global Klebsiella Pneumoniae Infection Drug Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Klebsiella Pneumoniae Infection Drug (2022-2027)

7.2 Global Forecasted Revenue of Klebsiella Pneumoniae Infection Drug (2022-2027)

7.3 Global Forecasted Price of Klebsiella Pneumoniae Infection Drug (2022-2027)

7.4 Global Forecasted Production of Klebsiella Pneumoniae Infection Drug by Region (2022-2027)

7.4.1 North America Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.3 Europe Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.7 Africa Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.9 South America Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Klebsiella Pneumoniae Infection Drug Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Application (2022-2027)

8 Global Klebsiella Pneumoniae Infection Drug Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

8.2 East Asia Market Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

8.3 Europe Market Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Countriy

8.4 South Asia Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

8.5 Southeast Asia Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

8.6 Middle East Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

8.7 Africa Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

8.8 Oceania Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

8.9 South America Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

8.10 Rest of the world Forecasted Consumption of Klebsiella Pneumoniae Infection Drug by Country

9 Global Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2027)

9.1 Global Klebsiella Pneumoniae Infection Drug Historic Market Size by Type (2016-2021)

9.2 Global Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Type (2022-2027)

10 Global Klebsiella Pneumoniae Infection Drug Consumption by Application (2016-2027)

10.1 Global Klebsiella Pneumoniae Infection Drug Historic Market Size by Application (2016-2021)

10.2 Global Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Application (2022-2027)

11 Global Klebsiella Pneumoniae Infection Drug Manufacturing Cost Analysis

11.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

12 Global Klebsiella Pneumoniae Infection Drug Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Klebsiella Pneumoniae Infection Drug Distributors List

12.3 Klebsiella Pneumoniae Infection Drug Customers

12.4 Klebsiella Pneumoniae Infection Drug Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Klebsiella Pneumoniae Infection Drug Revenue (US$ Million) 2016-2021

Table 6. Global Klebsiella Pneumoniae Infection Drug Market Size by Type (US$ Million): 2022-2027

Table 7. ATI-1503 Features

Table 8. CA-824 Features

Table 9. CC-1807 Features

Table 10. Cefiderocol Features

Table 11. Debio-1454 Features

Table 12. EBX-004 Features

Table 13. Others Features

Table 16. Global Klebsiella Pneumoniae Infection Drug Market Size by Application (US$ Million): 2022-2027

Table 17. Hospital Case Studies

Table 18. Clinic Case Studies

Table 19. Others Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Klebsiella Pneumoniae Infection Drug Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Klebsiella Pneumoniae Infection Drug Market Growth Strategy

Table 46. Klebsiella Pneumoniae Infection Drug SWOT Analysis

Table 47. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product Specification

Table 48. Acies Bio doo Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product Specification

Table 50. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product Specification

Table 52. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product Specification

Table 54. Table Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product Specification

Table 56. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product Specification

Table 58. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product Specification

Table 60. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Specification

Table 62. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product Specification

Table 64. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Specification

Table 66. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product Specification

Table 68. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product Specification

Table 70. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Pfizer Inc Klebsiella Pneumoniae Infection Drug Product Specification

Table 72. Pfizer Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product Specification

Table 74. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 75. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product Specification

Table 76. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 77. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product Specification

Table 78. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 79. Syntiron LLC Klebsiella Pneumoniae Infection Drug Product Specification

Table 80. Syntiron LLC Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 81. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product Specification

Table 82. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Klebsiella Pneumoniae Infection Drug Production Capacity by Market Players

Table 148. Global Klebsiella Pneumoniae Infection Drug Production by Market Players (2016-2021)

Table 149. Global Klebsiella Pneumoniae Infection Drug Production Market Share by Market Players (2016-2021)

Table 150. Global Klebsiella Pneumoniae Infection Drug Revenue by Market Players (2016-2021)

Table 151. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Market Players (2016-2021)

Table 152. Global Market Klebsiella Pneumoniae Infection Drug Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 155. North America Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 157. North America Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 159. East Asia Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 162. East Asia Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 164. East Asia Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 166. Europe Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 169. Europe Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 171. Europe Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 173. South Asia Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 176. South Asia Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 178. South Asia Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 180. Southeast Asia Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 183. Southeast Asia Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 185. Southeast Asia Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 187. Middle East Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 190. Middle East Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 192. Middle East Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 194. Africa Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 197. Africa Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 199. Africa Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 201. Oceania Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 204. Oceania Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 206. Oceania Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 208. South America Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 211. South America Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 213. South America Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 215. Rest of the World Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Klebsiella Pneumoniae Infection Drug Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Klebsiella Pneumoniae Infection Drug Market Share (2016-2021)

Table 218. Rest of the World Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Klebsiella Pneumoniae Infection Drug Market Share by Type (2016-2021)

Table 220. Rest of the World Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Klebsiella Pneumoniae Infection Drug Market Share by Application (2016-2021)

Table 222. North America Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 223. East Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 224. Europe Klebsiella Pneumoniae Infection Drug Consumption by Region (2016-2021)

Table 225. South Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 226. Southeast Asia Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 227. Middle East Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 228. Africa Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 229. Oceania Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 230. South America Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 231. Rest of the World Klebsiella Pneumoniae Infection Drug Consumption by Countries (2016-2021)

Table 232. Global Klebsiella Pneumoniae Infection Drug Production Forecast by Region (2022-2027)

Table 233. Global Klebsiella Pneumoniae Infection Drug Sales Volume Forecast by Type (2022-2027)

Table 234. Global Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Klebsiella Pneumoniae Infection Drug Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Klebsiella Pneumoniae Infection Drug Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Klebsiella Pneumoniae Infection Drug Sales Price Forecast by Type (2022-2027)

Table 238. Global Klebsiella Pneumoniae Infection Drug Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Klebsiella Pneumoniae Infection Drug Consumption Value Forecast by Application (2022-2027)

Table 240. North America Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 241. East Asia Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 242. Europe Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 243. South Asia Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 245. Middle East Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 246. Africa Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 247. Oceania Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 248. South America Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027 by Country

Table 250. Global Klebsiella Pneumoniae Infection Drug Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2016-2021)

Table 252. Global Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2022-2027)

Table 254. Global Klebsiella Pneumoniae Infection Drug Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application (2016-2021)

Table 256. Global Klebsiella Pneumoniae Infection Drug Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application (2022-2027)

Table 258. Klebsiella Pneumoniae Infection Drug Distributors List

Table 259. Klebsiella Pneumoniae Infection Drug Customers List





Figure 1. Product Figure

Figure 2. Global Klebsiella Pneumoniae Infection Drug Market Share by Type: 2021 VS 2027

Figure 3. Global Klebsiella Pneumoniae Infection Drug Market Share by Application: 2021 VS 2027

Figure 4. North America Klebsiella Pneumoniae Infection Drug Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 6. North America Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 7. United States Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 8. Canada Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 12. China Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 13. Japan Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 15. Europe Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate

Figure 16. Europe Klebsiella Pneumoniae Infection Drug Consumption Market Share by Region in 2021

Figure 17. Germany Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 19. France Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 20. Italy Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 21. Russia Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 22. Spain Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 25. Poland Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate

Figure 27. South Asia Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 28. India Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate

Figure 30. Southeast Asia Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 31. Indonesia Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate

Figure 37. Middle East Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 38. Turkey Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 40. Iran Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 42. Africa Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate

Figure 43. Africa Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 44. Nigeria Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate

Figure 47. Oceania Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 48. Australia Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 49. South America Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate

Figure 50. South America Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 51. Brazil Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Klebsiella Pneumoniae Infection Drug Consumption and Growth Rate

Figure 54. Rest of the World Klebsiella Pneumoniae Infection Drug Consumption Market Share by Countries in 2021

Figure 55. Global Klebsiella Pneumoniae Infection Drug Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Klebsiella Pneumoniae Infection Drug Price and Trend Forecast (2022-2027)

Figure 58. North America Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 59. North America Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 75. South America Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Klebsiella Pneumoniae Infection Drug Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Klebsiella Pneumoniae Infection Drug Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 79. East Asia Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 80. Europe Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 81. South Asia Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 82. Southeast Asia Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 83. Middle East Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 84. Africa Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 85. Oceania Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 86. South America Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 87. Rest of the world Klebsiella Pneumoniae Infection Drug Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Klebsiella Pneumoniae Infection Drug

Figure 89. Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Klebsiella Pneumoniae Infection Drug Supply Chain Analysis